Text Size

Organized Self-Management Support Services for Chronic Depression (Stride)

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Swedish Medical Center
Information provided by:
Group Health Cooperative
ClinicalTrials.gov Identifier:
NCT01139060
First received: June 4, 2010
Last updated: June 7, 2010
Last verified: June 2010
History of Changes
  Purpose

The purpose is to test the effectiveness of an organized care program for chronic or recurrent depression. Using a two-arm design, the investigators will randomly assign 300 participants with chronic or recurrent depression to one of two conditions: continued usual care (UC); or an 18-month organized treatment program focused on outreach and engagement, including a weekly group self-management training program, monthly visits with a psychotherapist (in-person or by telephone), and optional one-on-one visits with a peer support specialist. All intervention components are intended as adjuncts to any existing depression treatment (usually antidepressant medication) provided by participants' regular providers.


Condition Intervention
Depression
 Behavioral: organized care program for chronic or recurrent depression

Study Type: Interventional
Official Title: Organized Self-Management Support Services for Chronic Depression

Resource links provided by NLM:

MedlinePlus related topics: Depression
U.S. FDA Resources

Further study details as provided by Group Health Cooperative:

Primary Outcome Measures:
  • Evaluate the program's effectiveness

Secondary Outcome Measures:
  • Examination of moderators of treatment response
  • An estimate of the program's costs and effect on the costs of treatment for depression

Study Start Date: August 2009
Arms Assigned Interventions
Experimental: Intervention Group Behavioral: organized care program for chronic or recurrent depression
No Intervention: Usual Care

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • all patients will meet criteria for recurrent major depression or dysthymia

Exclusion Criteria:

  • bipolar disorder or psychotic disorder
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01139060

Locations
United States, Washington
Group Health Research Insitute
Seattle, Washington, United States, 98101
Swedish Cherry Hill Clinic
Seattle, Washington, United States
Sponsors and Collaborators
Group Health Cooperative
Swedish Medical Center
  More Information

No publications provided

Responsible Party: Evette Ludman, PhD, Research Associate, Group Health Research Institute
ClinicalTrials.gov Identifier: NCT01139060     History of Changes
Other Study ID Numbers: 5R01MH082995
Study First Received: June 4, 2010
Last Updated: June 7, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Group Health Cooperative:
chronic or recurrent depression

Additional relevant MeSH terms:
Depression
Depressive Disorder
Dysthymic Disorder
 Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013